EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand

Niveditha Rajadevan iD, Ariane Flinkier, Hugo Saunders, Yeh Chen Lee, Clare Scott, Pearly Khaw, Prue Allan, Claire Davies, John Andrews, Michelle Wilson, Janine M Lombard, Michelle Harrison und 4 weitere

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2024

DOI: 10.1111/ajo.13792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2024. Verfasst von Niveditha Rajadevan und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peter MacCallum Cancer Foundation, Peter MacCallum Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mucinous ovarian carcinoma (MOC) is a rare ovarian cancer with limited evidence to support clinical care.

Aims

We undertook a clinician survey to better understand current practice in treating MOC in Australia and New Zealand, and to determine any features associated with variation in care. In addition, we aimed to understand future research priorities.

Methods

A RedCap survey was distributed to clinician members of the Australia New Zealand Gynaecological Oncology Group (ANZGOG). Questions included respondent demographics, three case studies and future research priorities. Clinicians were asked questions specific to their speciality.

Results

Respondents ( n = 47) were commonly experienced gynae‐oncology specialists, most often surgical (38%) or medical (30%) oncologists. There was good consensus for surgical approaches for stage I disease; however, variation in practice was noted for advanced or recurrent MOC. Variation was also observed for medical oncologists; in early‐stage disease there was no clear consensus on whether to offer chemotherapy, or which regimen to recommend. For advanced and recurrent disease a wide range of chemotherapy options was considered, with a trend away from an ovarian‐type toward gastrointestinal (GI)‐type regimens in advanced MOC. This practice was reflected in future research priorities, with ‘Is a GI chemotherapy regimen better than an ovarian regimen?’ the most highly ranked option, followed by ‘Should stage 1C patients receive chemotherapy?’ Conclusions Although the number of respondents limited the analyses, it was clear that chemotherapy selection was a key point of divergence for medical oncologists. Future research is needed to establish well‐evidenced guidelines for clinical care of MOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPractice Patterns, Physicians'HumansFemaleNew ZealandAustraliaAdenocarcinoma, MucinousSurveys and QuestionnairesNeoplasm StagingOncologistsMedical OncologyGynecology

Stichwörter der Autor:innen

current practicemucinous ovarian cancerpatterns of caresurvey

Autor:innen und Institutionen

  • The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Prince of Wales Hospital and Royal Hospital for Women, Sydney, New South Wales, Australia.
  • The University of Sydney, Sydney, New South Wales, Australia.
  • School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Niveditha Rajadevan, Kylie L Gorringe

Förderung

  • Peter MacCallum Cancer Foundation
  • Peter MacCallum Foundation

Zitieren

APA

Rajadevan, N., Flinkier, A., Saunders, H., Lee, Y. C., Scott, C., Khaw, P., Allan, P., Davies, C., Andrews, J., Wilson, M., Lombard, J. M., Harrison, M., Nesfield, H., DeFazio, A., Meniawy, T., & Gorringe, K. L. (2024). Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13792

Vancouver

Rajadevan N, Flinkier A, Saunders H, Lee YC, Scott C, Khaw P, et al. Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2024. doi:10.1111/ajo.13792

BibTeX
@article{Rajadevan2024,
  author = {Rajadevan, Niveditha and Flinkier, Ariane and Saunders, Hugo and Lee, Yeh Chen and Scott, Clare and Khaw, Pearly and Allan, Prue and Davies, Claire and Andrews, John and Wilson, Michelle and Lombard, Janine M and Harrison, Michelle and Nesfield, Heshani and DeFazio, Anna and Meniawy, Tarek and Gorringe, Kylie L},
  title = {Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2024},
  doi = {10.1111/ajo.13792}
}
Kostenlos starten →